🇺🇸 FDA

Drug profile · INN

ivacaftor

KAFTRIO

approved R07AX32
US status
approved
Patents linked
0
News articles
1

Quick answer

ivacaftor (KAFTRIO) is an FDA-listed pharmaceutical active ingredient. Associated with Vertex Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN ivacaftor
Brand KAFTRIO
Route ORAL
Formulation GRANULE
ATC code R07AX32
Originator Vertex Pharmaceuticals (Ireland) Limited

Frequently asked questions

What is ivacaftor?

ivacaftor (KAFTRIO) is an FDA-listed pharmaceutical active ingredient. Associated with Vertex Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for ivacaftor?

KAFTRIO is a marketed brand name for ivacaftor. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ivacaftor?

ivacaftor has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.